Immunology of multiple sclerosis

scientific article published on 01 January 2005

Immunology of multiple sclerosis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1146/ANNUREV.IMMUNOL.23.021704.115707
P698PubMed publication ID15771584

P50authorMireia SospedraQ61308810
Roland MartinQ69171707
P921main subjectmultiple sclerosisQ8277
immunologyQ101929
P304page(s)683-747
P577publication date2005-01-01
P1433published inAnnual Review of ImmunologyQ567362
P1476titleImmunology of multiple sclerosis
P478volume23

Reverse relations

cites work (P2860)
Q34091080'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides
Q37776167A Consensus Statement Addressing Mesenchymal Stem Cell Transplantation for Multiple Sclerosis: It’s Time!
Q36984189A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms
Q50886047A Nanobiosensor Based on Fluorescent DNA-Hosted Silver Nanocluster and HCR Amplification for Detection of MicroRNA Involved in Progression of Multiple Sclerosis.
Q36635131A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica
Q33367112A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis
Q33857396A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice
Q42767100A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
Q38258366A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
Q30723942A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?
Q33306704A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases
Q36494088A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells.
Q61445020A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
Q35790269A study of experimental autoimmune encephalomyelitis in dogs as a disease model for canine necrotizing encephalitis
Q28256953A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease
Q34518133Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the centra
Q34639949Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases
Q33930062Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Q34986269Activation of endogenous neural stem cells for multiple sclerosis therapy
Q81122390Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?
Q35230209Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis
Q48175463Active induction of experimental allergic encephalomyelitis
Q37227771Acute disseminated encephalomyelitis: clinical and pathogenesis features.
Q35112101Administration of chinpi, a component of the herbal medicine ninjin-youei-to, reverses age-induced demyelination
Q33263472Age-related macular degeneration--emerging pathogenetic and therapeutic concepts
Q35101760Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis
Q39470133Agent-based modeling of the immune system: NetLogo, a promising framework
Q37321172Akt1 is critical for acute inflammation and histamine-mediated vascular leakage
Q42361890Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
Q43073589Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Q33701762Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Q41595215Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Q36428498Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis
Q45373997Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease
Q55244957Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
Q28732434Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm light
Q37311315An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action
Q40152964An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.
Q34499810Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions
Q38396248Animal models of Multiple Sclerosis.
Q38882149Anti-Inflammatory Effect of Wogonin on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-Polycytidylic Acid.
Q28080791Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases
Q36512334Antigen-induced Pten gene deletion in T cells exacerbates neuropathology in experimental autoimmune encephalomyelitis
Q37679881Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis
Q35671182Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Q37324056Astrocyte, the star avatar: redefined.
Q34777465Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis
Q24628925Atacicept: targeting B cells in multiple sclerosis
Q99573638Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15
Q83293324Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
Q33992633Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen
Q35214738Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
Q36007039Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity
Q50485184Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway.
Q36657652Autoimmune modulation of astrocyte-mediated homeostasis.
Q37667281Autophagy and Autophagy-Related Proteins in CNS Autoimmunity.
Q34686890Autophagy, inflammation and neurodegenerative disease
Q37006059Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis
Q37743241Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.
Q37313740B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients
Q35903957B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases
Q34544062B cells move to centre stage: novel opportunities for autoimmune disease treatment
Q37679878B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms
Q37671295BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis
Q26744116Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
Q47099956Bioactivity of Olive Oil Phenols in Neuroprotection.
Q42789516Biological outcome measurements for behavioral interventions in multiple sclerosis
Q26827146Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases
Q36516815Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation
Q38984981Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases
Q37193914Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Q35078327Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
Q64058668Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4 T Cells in Multiple Sclerosis
Q82810101Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE
Q26865295Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
Q48407284Brain protection conferred by long-term administration of 2-(2-benzofuranyl)-2-imidazoline against experimental autoimmune encephalomyelitis
Q35458567Brain-reactive antibodies and disease.
Q45936271Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG.
Q36299109Broad spectrum immune monitoring in immune-mediated inflammatory disorders
Q92531242Butyrate suppresses demyelination and enhances remyelination
Q35894777Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.
Q80455478CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE
Q37061386CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.
Q38732306CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm
Q37365433CD40 and autoimmunity: the dark side of a great activator.
Q34361334CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model
Q35571261CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
Q38779104CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells
Q64069827Calling in the Caalry- Hijacks GABAergic Signaling and Voltage-Dependent Calcium Channel Signaling for -Mediated Dissemination
Q37237452Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration
Q81478365Cannabinoids and multiple sclerosis
Q39119286Cannabinoids decrease the th17 inflammatory autoimmune phenotype
Q37316510Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism
Q31130538Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Q36089786Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Q34056814Cell replacement therapies to promote remyelination in a viral model of demyelination
Q57491432Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection
Q36416627Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Q50984358Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin.
Q36072420Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
Q21144285Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis
Q33912628Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability
Q91734156Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice
Q52566925Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Q34232425Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis
Q54285111Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
Q28478279Charge isomers of myelin basic protein: structure and interactions with membranes, nucleotide analogues, and calmodulin
Q33994547Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease
Q37055339Chronic exposure to water pollutant trichloroethylene increased epigenetic drift in CD4(+) T cells
Q33797172Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity
Q58115047Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
Q49165904Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Q33535660Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients
Q38070677Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
Q47225588Co-Transplantation of Human Neurotrophic Factor Secreting Cells and Adipose-Derived Stem Cells in Rat Model of Multiple Sclerosis
Q35166937Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis
Q97067655Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
Q50239453Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice
Q57296139Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
Q81356139Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level
Q26774368Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis
Q57062331Computational comparison of two new fusion proteins for multiple sclerosis
Q37208572Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
Q37313736Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Q36267838Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis
Q47892707Controlled Release of Second Generation mTOR Inhibitors to Restrain Inflammation in Primary Immune Cells
Q48241189Cortical atrophy is relevant in multiple sclerosis at clinical onset.
Q54261778Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
Q80584784Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1
Q36634895Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.
Q27680393Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop
Q36789308Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Q56573336Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease
Q92444762Csf1 Deficiency Dysregulates Glial Responses to Demyelination and Disturbs CNS White Matter Remyelination
Q35495245Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra
Q37793141Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis
Q36827362Current concepts of the cellular and molecular pathophysiology of multiple sclerosis
Q38911206Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Q34095225Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis
Q38751579Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Q35613492Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells
Q33863351Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
Q28534321Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism
Q52143402Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Q42363220Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.
Q35935131DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Q34349507DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele
Q37145510Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
Q33920152Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiation
Q34574703Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope
Q34428400Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype
Q33838749Design and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83-96) Epitope to Function as T-Cell Receptor Antagonists.
Q54937236Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions.
Q91576425Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
Q33582690Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.
Q92149773Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody
Q42030864Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.
Q38664253Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
Q37093197Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor
Q41832065Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells
Q33619976Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Q54209318Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
Q41771263Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in Sera
Q57814499Dimethyl fumarate as a first- vs second-line therapy in MS: Focus on B cells
Q61479730Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Q36416340Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
Q36300489Discovery of BVDU as a promising Drug for autoimmune diseases Therapy by Dendritic-cell-based functional screening
Q34151104Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
Q33625425Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Q37328280Disease-modifying agents for multiple sclerosis: recent advances and future prospects
Q38137114Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies
Q42094299Disruption of the beta2-integrin CD11d (alphaDbeta2) gene fails to protect against experimental autoimmune encephalomyelitis
Q36314027Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Q36577212Drug insight: using monoclonal antibodies to treat multiple sclerosis
Q46036987Dual role of Response gene to complement-32 in multiple sclerosis.
Q61445603Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients
Q34687561Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity
Q48178994Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination.
Q37578372EAE: an immunologist's magic eye.
Q40543886EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Q42322167Editorial: Lymphocytes in MS and EAE: More Than Just a CD4+ World
Q38636586Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.
Q41951909Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis
Q41020615Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.
Q55516350Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis.
Q34475830Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.
Q35082644Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis
Q37261686Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis
Q34712554Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis
Q36298955Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
Q37412980Eliminating encephalitogenic T cells without undermining protective immunity
Q37809764Emerging topics and new perspectives on HLA-G.
Q37991266End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.
Q35146806Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
Q22252381Environmental factors and their regulation of immunity in multiple sclerosis
Q34041828Environmental factors in early childhood are associated with multiple sclerosis: a case-control study
Q36145913Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
Q47140915Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets
Q27010680Epistasis and immunity: the role of genetic interactions in autoimmune diseases
Q36414419Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis
Q35697927Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Q55982210Epstein-Barr virus and multiple sclerosis
Q30878158Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Q26830464Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
Q35914342Epstein-barr virus: environmental trigger of multiple sclerosis?
Q34610594Estrogen and testosterone therapies in multiple sclerosis
Q36778684Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis
Q46325643Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.
Q37130888Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis
Q36474367Evidence for humoral autoimmunity in neuromyelitis optica
Q61971664Evolution of MS lesions to black holes under DNA vaccine treatment
Q33770508Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
Q50114920Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS).
Q35589934Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Q35563492Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection
Q36845899Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus.
Q38361889Exploring the origins of grey matter damage in multiple sclerosis.
Q37711026Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination
Q91725700Expression of CD1d by astrocytes corresponds with relative activity in multiple sclerosis lesions
Q34149191Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis
Q58720899Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis
Q90618608Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
Q52926000Extracellular Vesicles in Multiple Sclerosis as Possible Biomarkers: Dream or Reality?
Q28074658Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
Q44516794Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect
Q35052362Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
Q21195861Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle
Q37071856Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.
Q48442984Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis
Q37483492From genes to function: the next challenge to understanding multiple sclerosis
Q34571353Functional epistasis on a common MHC haplotype associated with multiple sclerosis
Q42318115Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis .
Q35986699Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Q36990042Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis
Q37112554G protein-coupled receptors as therapeutic targets for multiple sclerosis
Q47975519Gaining entry to an uninflamed brain
Q33725068Gammadelta T cells in EAE: early trafficking events and cytokine requirements
Q34277058Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis.
Q57061847Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
Q34659651Genetic association of rs1520333 G/A polymorphism in the IL7 gene with multiple sclerosis susceptibility in Isfahan population
Q33890981Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells
Q36866321Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis
Q51415619Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.
Q37165875Getting specific: monoclonal antibodies in multiple sclerosis.
Q36440629Glial toll-like receptor signaling in central nervous system infection and autoimmunity
Q37029694Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection
Q26853743Glucocorticoids and endothelial cell barrier function
Q36210121Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
Q26863405Gut commensalism, cytokines, and central nervous system demyelination
Q50097667Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.
Q79803676HLA class I: friend and foe of multiple sclerosis
Q36958285HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma
Q37151283HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
Q35782781HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
Q48445330Haptoglobin deficiency facilitates the development of autoimmune inflammation.
Q36283450Heat shock protein 70: roles in multiple sclerosis
Q40119805Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment.
Q33965239Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies
Q35589270Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation
Q57898104Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?
Q33778883Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Q52720499Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types.
Q36778303High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
Q38058619Hormone and immune system interactions in demyelinating disease
Q34170760Hsp70 and its molecular role in nervous system diseases
Q40275029Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.
Q58571221Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
Q41487863Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
Q34683399Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Q37253314Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.
Q35586871Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
Q37778884Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
Q51765773ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis.
Q36417195IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27
Q36509839IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development
Q59854924IL-10 suppressor activity andex vivo Tr1 cell function are impaired in multiple sclerosis
Q37008475IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen
Q37865163IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Q36142154IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination
Q24338636IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production
Q37085543IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis
Q47680353IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.
Q33998401IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages
Q36416533Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation
Q33378475Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms
Q33953320Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation
Q34835462Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach
Q38902001Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors
Q34599027Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response
Q91787847Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients
Q36151968Immune modulating peptides for the treatment and suppression of multiple sclerosis
Q36841506Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone
Q52893492Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.
Q33886414Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis
Q82709302Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
Q48965109Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives
Q36280862Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Q80426447Immunology of multiple sclerosis
Q27016045Immunology of neuromyelitis optica: a T cell-B cell collaboration
Q38937346Immunometabolism and autoimmunity
Q36067334Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Q34448370Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity
Q36577275Immunopathogenesis and immunotherapy of multiple sclerosis
Q36832873Immunopathogenesis of multiple sclerosis
Q36198757Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Q26745562Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
Q34093041Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions
Q34622205Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial
Q34538700Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis
Q34077547Impaired neurosteroid synthesis in multiple sclerosis.
Q90263600Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Q57798606Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct
Q33490992Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system
Q37121507Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis
Q34971488Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide
Q30908652Infection risk in patients on multiple sclerosis therapeutics
Q54635826Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease.
Q37591113Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Q44497613Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis
Q38156767Initial immunopathogenesis of multiple sclerosis: innate immune response.
Q38118170Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis
Q63363253Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Q39622523Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.
Q34544891Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis
Q51025796Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Q79613933Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis
Q34482841Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients
Q34680345Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis
Q80335293Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift?
Q24681662Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
Q34937637Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.
Q35780751Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Q42282484Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection.
Q36315737Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.
Q36571278Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice
Q42131303Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration
Q59355260Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects
Q36108869Intrathecal T-cell clonal expansions in patients with multiple sclerosis
Q36359691Intravenous immunoglobulin and multiple sclerosis
Q28083069Invariant natural killer T cells and their ligands: focus on multiple sclerosis
Q26774642Involvement of CD8(+) T Cells in Multiple Sclerosis
Q38962165Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Q91994956Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
Q55347930Is there a link between inflammation and fatigue in multiple sclerosis?
Q42341307Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?
Q37605028Isolation and th17 differentiation of naïve CD4 T lymphocytes.
Q59349868KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects
Q36768701Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Q37085783Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis
Q33528993Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis
Q34249594Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis
Q92051349Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
Q84622973Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis
Q47616930Lewis Rat Model of Experimental Autoimmune Encephalomyelitis
Q92432120Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
Q36887316Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis
Q33761191Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues
Q37245952Lithium prevents and ameliorates experimental autoimmune encephalomyelitis
Q28075478Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis
Q37304845Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity
Q38101013Liver X receptors, nervous system, and lipid metabolism.
Q34409257Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
Q37696989Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Q49164654Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
Q60301285Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS
Q34291918Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
Q47963320Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
Q36637406Loss of electrostatic cell-surface repulsion mediates myelin membrane adhesion and compaction in the central nervous system
Q47999107Loss of β-arrestin 2 exacerbates experimental autoimmune encephalomyelitis with reduced number of Foxp3+ CD4+ regulatory T cells
Q36590210Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death
Q36430136MHC class II proteins and disease: a structural perspective
Q36342130MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination
Q46234913MIF and D-DT are potential disease severity modifiers in male MS subjects
Q34370104MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Q36154032MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum
Q33233907MRI-guided immunotherapy development for multiple sclerosis in a primate
Q35601282MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity
Q90564159Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis
Q35928741Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE.
Q36013705Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Q37578015Mast cell modulation of the immune response
Q92030412Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis
Q33740585MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.
Q37414117Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases
Q90453420Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review
Q29617977Mechanisms underlying inflammation in neurodegeneration
Q51825411Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.
Q36061629Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Q37354623Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.
Q58709181Memory B Cells Activate Brain-Homing, Autoreactive CD4 T Cells in Multiple Sclerosis
Q36652220Mesenchymal stem cells are mobilized from the bone marrow during inflammation
Q34247703Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis
Q28575785Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Q37728572MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium
Q28509195MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
Q38645580MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of Autoimmune Neuroinflammation.
Q35974243MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination
Q33243924Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis
Q22252213Microbial view of central nervous system autoimmunity
Q36995320Microglia play a major role in direct viral-induced demyelination
Q38131730Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
Q34124465Microwave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.
Q30435441Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis
Q28265793Mini review: immune response to myelin-derived sulfatide and CNS-demyelination
Q91982232Mitochondrial Dysfunction and Multiple Sclerosis
Q92365106Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients
Q36286370Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis
Q37119854Modeling the heterogeneity of multiple sclerosis in animals
Q30483471Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Q48630939Modulating the immune system through nanotechnology.
Q37007219Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Q36832884Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
Q48354362Molecular Genetic and Epigenetic Basis of Multiple Sclerosis
Q55617506Molecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases.
Q35197096Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
Q33753720Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy
Q24613288Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
Q36885184Molecular targets for disrupting leukocyte trafficking during multiple sclerosis
Q37814815Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges
Q30840308Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp mice
Q90049708Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis
Q37788598Multiple Sclerosis Therapies: Molecular Mechanisms and Future
Q41525680Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production
Q39420793Multiple Sclerosis: Immunopathology and Treatment Update
Q64912153Multiple Sclerosis: New Aspects of Immunopathogenesis.
Q37785133Multiple functional targets of the immunoregulatory activity of galectin-1: Control of immune cell trafficking, dendritic cell physiology, and T-cell fate.
Q37776054Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms
Q43136157Multiple sclerosis and the blood-central nervous system barrier
Q36832911Multiple sclerosis as a painful disease
Q43635768Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
Q37040077Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Q37150347Multiple sclerosis, blood flow, and CSF circulation
Q36032150Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor
Q36915907Multiple sclerosis: a complicated picture of autoimmunity.
Q43125787Multiple sclerosis: closing in on an oral treatment.
Q84390184Multiple sclerosis: human model for EAE?
Q35683398Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.
Q34342662Multiple sclerosis: overview of disease-modifying agents
Q79196544Multiple sclerosis: putting two and two together
Q60949833Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients
Q35891605Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis
Q38156034Myelin architecture: zippering membranes tightly together
Q36562052Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice
Q80171702Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype
Q35146791Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation
Q52576677NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.
Q40786516Nano- and micro-based systems for immunotolerance induction in multiple sclerosis
Q57486472Naringenin Modifies the Development of Lineage-Specific Effector CD4 T Cells
Q34994463Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b
Q37213706Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
Q37124504Natural killer cells and their receptors in multiple sclerosis
Q36166679Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis
Q37343069Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients
Q91338016Nav1.5 in astrocytes plays a sex-specific role in clinical outcomes in a mouse model of multiple sclerosis
Q35484427Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood
Q33821451Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice
Q26864449Neuroendocrine immunoregulation in multiple sclerosis
Q36228999Neurofascin as a novel target for autoantibody-mediated axonal injury
Q37424844Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
Q33893135Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system
Q48380050Neuronal degeneration in a viral model of multiple sclerosis
Q36869524Neuropathic pain in animal models of nervous system autoimmune diseases
Q24645165Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1
Q27023974Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration
Q84080843Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis
Q34389528New approaches in the management of multiple sclerosis
Q37057309New developments in understanding and treating neuroinflammation.
Q34466301Niacin activates the PI3K/Akt cascade via PKC- and EGFR-transactivation-dependent pathways through hydroxyl-carboxylic acid receptor 2.
Q24645400Nitric oxide and peroxynitrite in health and disease
Q39010894Nogo-A Antibodies for Progressive Multiple Sclerosis
Q28742885Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis
Q33507097Non-Linear Optical Imaging of Obesity-Related Health Risks: Review
Q55518857Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict early conversion into clinically definite multiple sclerosis.
Q92709805Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients
Q37952793Notch and inflammatory T-cell response: new developments and challenges
Q34039982Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits
Q40694500Novel Function of Extracellular Matrix Protein 1 in Suppressing Th17 Cell Development in Experimental Autoimmune Encephalomyelitis.
Q47948774Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice.
Q37781515Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
Q27314385Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling
Q39110118Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence
Q50644022OMIP-033: A comprehensive single step staining protocol for human T- and B-cell subsets.
Q42622912OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
Q90050581Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration
Q36598778Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
Q61811854Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients
Q35954507Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination
Q48853057Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.
Q81083982Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve
Q37568350Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Q56914273Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
Q28076588Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Q91843413Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment
Q41673047Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
Q46412279Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models
Q36830152Oral disease-modifying treatments for multiple sclerosis: the story so far.
Q36716680Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines
Q24337079Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease
Q34094680PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis
Q24296651PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Q34428066PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.
Q33591700PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model
Q36750245PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices
Q36356190PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
Q37626083Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation
Q35510088Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy
Q37210758Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects
Q80285957Passive induction of experimental allergic encephalomyelitis
Q36961069Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.
Q38008365Pathogenic CD8 T cells in multiple sclerosis and its experimental models
Q81437623Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues
Q57465762Pathological transitions in myelin membranes driven by environmental and multiple sclerosis conditions
Q36965753Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
Q42418046Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis
Q64072217Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation
Q38654791Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
Q36528981Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis
Q36528985Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia
Q38128224Perspectives of the relationship between IL-7 and autoimmune diseases.
Q35949095Pharmacokinetics of Py-Im polyamides depend on architecture: cyclic versus linear
Q48784902Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis
Q24311954Phosphorylation of U24 from Human Herpes Virus type 6 (HHV-6) and its potential role in mimicking myelin basic protein (MBP) in multiple sclerosis
Q34807106Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress
Q37100959Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Q24236418Plasma exchange for multiple sclerosis
Q94398401Plasma exchange for multiple sclerosis
Q36567230Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
Q34117705Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta
Q30977483Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data
Q33768549Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors
Q37957892Potential impact of B cells on T cell function in multiple sclerosis
Q36781267Potential of urinary metabolites for diagnosing multiple sclerosis
Q38930119Potential targeting of B7-H4 for the treatment of cancer.
Q34624709Potential triggers of MS
Q28553993Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy
Q34105985Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis
Q37081321Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7
Q52145132Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Q48820703Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy
Q37362453Promiscuous drugs as therapeutics for chemokine receptors
Q34828914Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis
Q36604126Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis
Q36228251Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Q35135555Psyche and soma: New insights into the connection
Q31014036Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis
Q43113841Quantified CSF antibody reactivity against myelin in multiple sclerosis
Q64953964Radon Therapy for Autoimmune Diseases Pemphigus and Diabetes: 2 Case Reports.
Q37401147Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Q28740839Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis
Q24812119Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity
Q36976664Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors
Q39302587Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
Q34053766Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis : Analysis of Economic Data from the CLARITY Study
Q35744057Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
Q34645439Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients
Q85209692Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients
Q38909429Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis
Q36039356Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway
Q39032832Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.
Q30574747Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells
Q37619855Relevance of molecular mimicry in the mediation of infectious myocarditis
Q61443079Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
Q81461292Requirement of the Fc receptor common gamma-chain for gamma delta T cell-mediated promotion of murine experimental autoimmune encephalomyelitis
Q36700407Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor
Q36494558Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
Q30278584Revisiting the Mechanisms of CNS Immune Privilege
Q33849373Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
Q36832863Role of B cells in pathogenesis of multiple sclerosis
Q28298240Role of IL-15 in immune-mediated and infectious diseases
Q26795528Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms
Q35721897Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
Q38562775Role of autophagy in the pathogenesis of multiple sclerosis
Q37735773Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.
Q35206805Role of pathogens in multiple sclerosis
Q38114422Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis
Q38384621Role of the innate and adaptive immune responses in the course of multiple sclerosis
Q33787624Role of the innate immune system in the pathogenesis of multiple sclerosis
Q37021687Role of toll-like receptors in multiple sclerosis
Q27325607SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens
Q89865080STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination
Q35819291STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
Q35244158Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study
Q39313856Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis
Q37009992Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
Q36562595Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
Q33645392Sex-dependent treatment of chronic EAE with partial MHC class II constructs
Q58784650Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Q34673043Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity
Q36298402Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis
Q40882468Simulation of spread and control of lesions in brain
Q47209789Simultaneous inference of phenotype-associated genes and relevant tissues from GWAS data via Bayesian integration of multiple tissue-specific gene networks.
Q58326709Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis
Q36683168Sinomenine reduces iNOS expression via inhibiting the T-bet IFN-γ pathway in experimental autoimmune encephalomyelitis in rats
Q39926496Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis
Q36527783SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.
Q35489039Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release
Q38204275Sphingosine-1 phosphate and central nervous system
Q24683357Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport
Q37165311Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response
Q35902446Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
Q89977191Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
Q34651994Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study
Q36404007Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
Q27667717Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis
Q27666863Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection
Q33947114Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule
Q36228518Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus
Q40196823Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.
Q42589482Synergistic activity of interleukin-17 and tumor necrosis factor-α enhances oxidative stress-mediated oligodendrocyte apoptosis
Q37197381Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis
Q34463760Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration
Q37174203Systems biology approaches for the study of multiple sclerosis
Q43457921T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
Q33723154T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis
Q50898570T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Q30433284TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
Q34171867TCR recognition of peptide/MHC class II complexes and superantigens
Q34418098TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
Q40157170TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy
Q42271141TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells
Q38706801Taming of macrophage and microglial cell activation by microRNA-124.
Q35295564Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
Q35595092Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis
Q37730005Teriflunomide and its mechanism of action in multiple sclerosis
Q37483670Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation.
Q37805082Th17 cells in inflammation
Q64075187The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)D Induces Super-Enhancers Bound by VDR
Q93015537The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases
Q42280869The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis
Q37151141The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
Q90393448The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
Q47252742The Gut Microbiome in Neuromyelitis Optica
Q54957634The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.
Q53287408The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18
Q38115525The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
Q36216025The Role of Latently Infected B Cells in CNS Autoimmunity
Q55431606The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.
Q42820908The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II
Q33595360The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
Q85174183The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood
Q34732881The clinical potential of blood-proteomics in multiple sclerosis
Q33685823The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration
Q37273745The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis
Q35294476The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis
Q38500852The crucial role of mast cells in blood-brain barrier alterations
Q37728840The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Q92186838The dark side of antiviral T cell responses
Q36420375The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Q24648473The endocannabinoid system as an emerging target of pharmacotherapy
Q34979322The epigenetics of autoimmunity
Q37830018The human microbiome in multiple sclerosis: pathogenic or protective constituents?
Q34776567The immunogenetics of multiple sclerosis
Q37857982The immunopathophysiology of multiple sclerosis
Q41859500The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components
Q34081672The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells
Q42484597The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells.
Q84281957The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
Q28541466The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response
Q26770815The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
Q92463066The protective role of TBX21-1514T>C polymorphism in susceptibility to multiple sclerosis
Q36171258The relevance of cortical lesions in patients with multiple sclerosis
Q38172891The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus.
Q36474320The role of CD4+ T-cells in the development of MS.
Q36474330The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis
Q52669235The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
Q90518839The role of chemokines and chemokine receptors in multiple sclerosis
Q34468304The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Q34087938The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice
Q47093555The roles of RGMa-neogenin signaling in inflammation and angiogenesis
Q38685035The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
Q31122077The spectrum of neuromyelitis optica
Q36027486The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.
Q26824619The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis
Q24534346The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
Q36291069Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?
Q33785953Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease
Q26991746Therapeutic potential of mesenchymal stem cells for oral and systemic diseases
Q33610240Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair
Q34053912Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2
Q33851359Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Q35867011Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis
Q64085734Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
Q38098448Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system
Q37780481Transgenic mouse models of multiple sclerosis
Q36614273Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients
Q37191628Transmethylation in immunity and autoimmunity
Q46474640Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response
Q89505804Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets
Q28484146Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system
Q46932120Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.
Q37884434Treatment of multiple sclerosis: current concepts and future perspectives
Q36299378Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Q43568427Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
Q37486214Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation
Q36635630Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice
Q30580359Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis
Q39315038Type I interferon pathway in CNS homeostasis and neurological disorders.
Q45720900Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells.
Q34188446Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Q37257176Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions
Q43437323Upregulation of β-1,4-galactosyltransferase I in rat spinal cord with experimental autoimmune encephalomyelitis
Q35424431Uptake and presentation of myelin basic protein by normal human B cells
Q88346915Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients
Q37651099Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital
Q35738486Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases
Q35888466Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
Q37085898Vaccines for multiple sclerosis: progress to date
Q33350182Variants of ST8SIA1 are associated with risk of developing multiple sclerosis
Q59543708Variations of the perforin gene in patients with multiple sclerosis
Q34750423Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis
Q93079858Virgin Olive Oil and Health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018
Q35123080Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis
Q47639897Western lifestyle and immunopathology of multiple sclerosis
Q30454634What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Q36257285Without nerves, immunology remains incomplete -in vivo veritas
Q51890165[Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].
Q82620795[Multiple sclerosis -- a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration]
Q83217436[Multiple sclerosis and exercise : effects of physical activity on the immune system]
Q51958899[Targeting B cells in multiple sclerosis. Current concepts and strategies].
Q35539301beta2-integrins in demyelinating disease: not adhering to the paradigm
Q36248231gammadelta T cells: the overlooked T-cell subset in demyelinating disease
Q49139961miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
Q42182365miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6.
Q37871931miRNAs stem cell reprogramming for neuronal induction and differentiation
Q35855614p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis
Q35632530αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features

Search more.